First Time Loading...

Meridian Bioscience Inc
NASDAQ:VIVO

Watchlist Manager
Meridian Bioscience Inc Logo
Meridian Bioscience Inc
NASDAQ:VIVO
Watchlist
Price: 33.97 USD Market Closed
Updated: May 14, 2024

Meridian Bioscience Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Meridian Bioscience Inc
Income from Continuing Operations Peer Comparison

Comparables:
COO
XRAY
ALGN
LNTH

Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
Meridian Bioscience Inc
NASDAQ:VIVO
Income from Continuing Operations
$42.5m
CAGR 3-Years
20%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Cooper Companies Inc
NYSE:COO
Income from Continuing Operations
$290.8m
CAGR 3-Years
-49%
CAGR 5-Years
-5%
CAGR 10-Years
0%
DENTSPLY SIRONA Inc
NASDAQ:XRAY
Income from Continuing Operations
-$92m
CAGR 3-Years
N/A
CAGR 5-Years
39%
CAGR 10-Years
N/A
Align Technology Inc
NASDAQ:ALGN
Income from Continuing Operations
$462.2m
CAGR 3-Years
0%
CAGR 5-Years
4%
CAGR 10-Years
13%
Lantheus Holdings Inc
NASDAQ:LNTH
Income from Continuing Operations
$460.5m
CAGR 3-Years
N/A
CAGR 5-Years
61%
CAGR 10-Years
N/A

See Also

What is Meridian Bioscience Inc's Income from Continuing Operations?
Income from Continuing Operations
42.5m USD

Based on the financial report for Sep 30, 2022, Meridian Bioscience Inc's Income from Continuing Operations amounts to 42.5m USD.

What is Meridian Bioscience Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
15%

Over the last year, the Income from Continuing Operations growth was -41%. The average annual Income from Continuing Operations growth rates for Meridian Bioscience Inc have been 20% over the past three years , 15% over the past five years .